<DOC>
	<DOCNO>NCT01034787</DOCNO>
	<brief_summary>This Phase 2 , multi-center , open-label study patient surgically incurable stage III IV uveal melanoma receive prior immunotherapy . CP-675,206 thought stimulate patient ' immune system attack tumor . CP-675,206 show induce durable tumor response patient metastatic melanoma phase 1 phase 2 clinical study .</brief_summary>
	<brief_title>Study AntiCTLA4 Patients With Unresectable Metastatic Uveal Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Uveal Neoplasms</mesh_term>
	<mesh_term>Tremelimumab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Histologically confirm uveal melanoma include choroidal melanoma , iris melanoma , ciliary body melanoma Patients may either measurable disease nonmeasurable disease . Biopsies readily accessible site disease study enrollment mandatory principle . Waivers grant accessible lesion . The collection representative block diagnostic tumour tissue ( available ) mandatory . ECOG performance status 0 1 Age 18 year old Adequate bone marrow , hepatic , renal function determine within 14 day prior registration , define : Serum lactic acid dehydrogenase ( LDH ) &lt; /= 1.5 x ULN . Alkaline phosphatase ( ALP ) &lt; /= 2 x ULN . No weight loss &gt; /= 10 % proceed 4 week . CT scan brain contrast MRI brain within 28 day registration show evidence brain metastasis . Females childbearing potential must negative serum urine pregnancy test within 14 day prior registration . Females undergone surgical sterilization postmenopausal least 2 year consider childbearing potential . Females childbearing potential male undergone surgical sterilization must agree practice form effective contraception prior entry study 12 month follow last dose study drug . The definition effective contraception base judgment investigator . Melanoma cutaneous , mucosal conjunctival origin . History brain leptomeningeal metastasis . Received prior CTLA4 inhibiting agent ( eg MDX010 , ipilimumab ) immunotherapy . History chronic inflammatory autoimmune disease History uveitis melanomaassociated retinopathy . History inflammatory bowel disease , celiac disease , chronic gastrointestinal condition associate diarrhea bleeding , current acute colitis origin . History hepatitis due Hepatitis B virus Hepatitis C virus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>CP-675,206</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>AntiCTLA4</keyword>
	<keyword>Clinical Trial</keyword>
	<keyword>Unresectable Metastatic</keyword>
</DOC>